Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for non-motor symptoms in idiopathic Parkinson's disease
2010-021394-37Phase 4Completed
- Sponsor
- UCB
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rotigotine with Placebo (2 arms). Primary endpoint: Change from baseline to end of maintenance in total NMSS score. Started Dec 2010; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-021394-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021394-37.